| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 02/02/2005 | EP1501808A1 Tachykinin receptor antagonists |
| 02/02/2005 | EP1501807A1 Sulfonylquinoxalone acetamide derivatives and related compounds as bradykinin antagonists |
| 02/02/2005 | EP1501805A1 Substituted pyrazolyl compounds for the treatment of inflammation |
| 02/02/2005 | EP1501797A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501796A1 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo[b]thiophene-2-carboxylic acid derivatives as interleukin-4 gene expression inhibitors |
| 02/02/2005 | EP1501795A1 Cinnamic acid amides |
| 02/02/2005 | EP1501787A1 N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 02/02/2005 | EP1501515A1 Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/02/2005 | EP1501514A2 Protein kinase modulators and methods of use |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | EP1297175A4 Methods and compounds for modulating nuclear receptor coactivator binding |
| 02/02/2005 | EP1292591B1 Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 02/02/2005 | EP1286955B1 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides |
| 02/02/2005 | CN1575283A Piperazine derivatives with CCRI receptor antagonist activity |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1575177A Cxcr3 antagonists |
| 02/02/2005 | CN1575176A Process for making substituted pyrazoles |
| 02/02/2005 | CN1575171A Novel anti-diabetic agents |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1187342C Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists |
| 02/02/2005 | CN1187333C Certain substituted caprolactams, pharmaceutical compositions containing them and their use in treating tumors |
| 02/02/2005 | CN1187326C Novel compounds |
| 02/02/2005 | CN1187325C Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849713 Topisomerase inhibitor |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849647 Amide compounds and medications containing the same technical field |
| 02/01/2005 | US6849643 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/01/2005 | US6849639 Anticancer agents, antiinflamatory agents, osteoporosis, atherosclerosis |
| 02/01/2005 | US6849636 Useful for treatment of noninsulin-dependent diabetes, hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome |
| 02/01/2005 | US6849633 Pyrazole derivative, production process thereof, and pest control agent containing the same as active ingredient |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849629 Heteroaromatic substituted sulfonyl or sulfoxide or thio-pyridazinone derivatives, useful for treating diabetic complications and cardiovascular disorders |
| 02/01/2005 | US6849622 May be useful for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, and for prophylaxis and treatment of other diseases induced or exacerbated by impaired glucose tolerance |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 02/01/2005 | US6849367 Photoconductive layer containing azo compound; electrostaticlatent image |
| 02/01/2005 | CA2166326C Pyridazinone derivatives |
| 01/27/2005 | WO2005007649A1 Improved process for preparing alpha-polymorphic eletriptan hydrobromide |
| 01/27/2005 | WO2005007648A2 Biaryl piperazinyl-pyridine analogues |
| 01/27/2005 | WO2005007647A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | WO2005007633A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 01/27/2005 | WO2005007625A2 Heterocyclic amides with anti-tuberculosis activity |
| 01/27/2005 | WO2005007165A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | WO2005007157A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | WO2004101512A3 Naphthyridine integrase inhibitors |
| 01/27/2005 | WO2004098518A3 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/27/2005 | WO2004069794B1 New arylpiperazinyl compounds |
| 01/27/2005 | WO2004064741A3 Compounds, compositions, and methods |
| 01/27/2005 | US20050020857 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 01/27/2005 | US20050020663 Improved preparation of alpha -polymorphic eletriptan hydrobromide, by salt formation in a solution of 2-butanone and water, distillation, dehydration, desolventizing; purity, white color crystals |
| 01/27/2005 | US20050020661 Antidiabetic agents |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020655 Transamination of ondansetron by a Mannich reaction |
| 01/27/2005 | US20050020654 Novel PPAR agonists, pharmaceutical compositions and uses thereof |
| 01/27/2005 | US20050020653 Imidazolyl or benzimidazolyl derivatives of triazole compounds substituted at 2 position; anti-fungal agent with broad spectrum activity useful in the treatment of fungal infections in animals, including humans and as agricultural fungicides |
| 01/27/2005 | US20050020652 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 01/27/2005 | US20050020617 3-substituted oxindole beta3 agonists |
| 01/27/2005 | US20050020604 5-HT receptor ligands and uses thereof |
| 01/27/2005 | US20050020601 Novel pyrazinones as CRF1 receptor antagonists |
| 01/27/2005 | US20050020586 Using 4-imidazoline ester or acid; antiinflammatory agents; microbiocides; bactericides; antitumor agents; autoimmune disease |
| 01/27/2005 | US20050020578 Oxidoreductase enzyme inhibitors such as (R)-1-[4-(2-methyl-4-phenyl-5,8-dihydro-6H-pyrido[3,4-d]pyrimidin-7-yl)-pyrimidin-2-yl-ethanol, used as antidiabetic agents |
| 01/27/2005 | US20050020576 Opioid antagonist; analgesics; antiinflammatory agents; side effect reduction |
| 01/27/2005 | US20050020573 5HT2c receptor modulators |
| 01/27/2005 | CA2532316A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 01/27/2005 | CA2532152A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 01/27/2005 | CA2532111A1 Improved process for preparing alpha-polymorphic eletriptan hydrobromide |
| 01/27/2005 | CA2531619A1 Biaryl piperazinyl-pyridine analogues |
| 01/27/2005 | CA2531508A1 Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| 01/27/2005 | CA2529790A1 Heteroaryloxy nitrogenous saturated heterocyclic derivative |
| 01/26/2005 | EP1500657A1 Substituted pyrazoles as P38 kinase inhibitors |
| 01/26/2005 | EP1500655A1 New methionine aminopeptidase inhibitor |
| 01/26/2005 | EP1500653A1 Substituted arylpyrazines |
| 01/26/2005 | EP1500652A1 Quinazoline derivative and medicine |
| 01/26/2005 | EP1499623A1 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one |
| 01/26/2005 | EP1499608A1 Substituted imidazole derivatives: gaba a receptor ligands |
| 01/26/2005 | EP1499599A1 Substituted pyrazine derivatives |
| 01/26/2005 | EP1499598A1 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| 01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499577A1 2-(2,6-dichlorophenyl)-diarylimidazoles |
| 01/26/2005 | EP1499319A1 Bicyclo 4.4.0 antiviral derivatives |
| 01/26/2005 | EP1499305A2 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 01/26/2005 | EP1379522B1 DIHYDRO-BENZO(b)(1,4)DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS I |
| 01/26/2005 | EP1373255B1 Process for the preparation of imidazole compounds |
| 01/26/2005 | EP1296976B1 Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them |
| 01/26/2005 | EP0844877B1 Use of oxido-squalene cyclase inhibitors to lower blood cholesterol |
| 01/26/2005 | CN1571783A Substituted alkylaminopyridazinone derivatives, process for the preparation thereof and pharmaceutical composition containing the same |
| 01/26/2005 | CN1571781A 4-imidazolin-2-one compounds |
| 01/26/2005 | CN1571774A Pyrimidinones as melanin concentrating hormone receptor 1 |
| 01/26/2005 | CN1571667A Inhibitors of dipeptidyl peptidase ó¶ |
| 01/26/2005 | CN1186339C Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 01/26/2005 | CN1186328C Substd. 5-benzyl-2, 4-diaminopyrimidines |
| 01/26/2005 | CN1186326C Propane-1, 3-dione derivatives |
| 01/26/2005 | CN1186322C Proline derivatives and use thereof as drugs |
| 01/25/2005 | US6846929 A hydroxyphenyl-2-benzotriazoles as light stabilizers having ultraviolet light absorbing activity; stabilizer with heat resistance, photostability, oxidation resistance |
| 01/25/2005 | US6846928 Compositions useful as inhibitors of protein kinases |
| 01/25/2005 | US6846840 Alkylating agents possessing both in vitro cytotoxicity and antitumor activity; for therapy of cancer |
| 01/25/2005 | US6846839 Identifying indolinone compounds that inhibit growth factor stimulated cell proliferation by contacting cells with compounds and with selected growth factors and monitoring inhibitory effect |
| 01/25/2005 | US6846834 Antiinflammation agents |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |